Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 184

1.

Cancer gene therapy utilizing interleukin-13 receptor alpha2 chain.

Kawakami K.

Curr Gene Ther. 2005 Apr;5(2):213-23. Review.

PMID:
15853729
[PubMed - indexed for MEDLINE]
2.
3.

Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer.

Kawakami K, Kawakami M, Joshi BH, Puri RK.

Cancer Res. 2001 Aug 15;61(16):6194-200.

PMID:
11507072
[PubMed - indexed for MEDLINE]
Free Article
4.
5.

Evidence that IL-13R alpha2 chain in human glioma cells is responsible for the antitumor activity mediated by receptor-directed cytotoxin therapy.

Kawakami K, Kioi M, Liu Q, Kawakami M, Puri RK.

J Immunother. 2005 May-Jun;28(3):193-202.

PMID:
15838375
[PubMed - indexed for MEDLINE]
6.

Adenoviral vector-mediated gene transfer of IL-13Ralpha2 chain followed by IL-13 cytotoxin treatment offers potent targeted therapy for cytotoxin-resistant cancers.

Saito M, Murata T, Watanabe K, Kawakami K, Suzuki M, Koji T, Puri RK, Kitazato K, Kobayashi N.

Int J Cancer. 2005 Aug 10;116(1):1-8.

PMID:
15756691
[PubMed - indexed for MEDLINE]
7.

Cytokine receptor as a sensitizer for targeted cancer therapy.

Kawakami K, Kawakami M, Puri RK.

Anticancer Drugs. 2002 Aug;13(7):693-9. Review.

PMID:
12187325
[PubMed - indexed for MEDLINE]
8.
9.

Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo.

Kawakami K, Kawakami M, Husain SR, Puri RK.

Gene Ther. 2003 Jul;10(13):1116-28.

PMID:
12808442
[PubMed - indexed for MEDLINE]
11.

Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.

Kioi M, Kawakami M, Shimamura T, Husain SR, Puri RK.

Cancer. 2006 Sep 15;107(6):1407-18.

PMID:
16902988
[PubMed - indexed for MEDLINE]
Free Article
12.

Interleukin 13 mediates signal transduction through interleukin 13 receptor alpha2 in pancreatic ductal adenocarcinoma: role of IL-13 Pseudomonas exotoxin in pancreatic cancer therapy.

Shimamura T, Fujisawa T, Husain SR, Joshi B, Puri RK.

Clin Cancer Res. 2010 Jan 15;16(2):577-86. doi: 10.1158/1078-0432.CCR-09-2015. Epub 2010 Jan 12.

PMID:
20068108
[PubMed - indexed for MEDLINE]
Free Article
13.
14.

Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases.

Joshi BH, Hogaboam C, Dover P, Husain SR, Puri RK.

Vitam Horm. 2006;74:479-504. Review.

PMID:
17027527
[PubMed - indexed for MEDLINE]
15.

Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.

Kioi M, Kawakami K, Puri RK.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6231-8.

PMID:
15448012
[PubMed - indexed for MEDLINE]
Free Article
16.

Sensitization of cancer cells to interleukin 13-pseudomonas exotoxin-induced cell death by gene transfer of interleukin 13 receptor alpha chain.

Kawakami K, Joshi BH, Puri RK.

Hum Gene Ther. 2000 Sep 1;11(13):1829-35.

PMID:
10986556
[PubMed - indexed for MEDLINE]
17.

Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.

Kawakami K, Terabe M, Kawakami M, Berzofsky JA, Puri RK.

Cancer Res. 2006 Apr 15;66(8):4434-42.

PMID:
16618770
[PubMed - indexed for MEDLINE]
Free Article
18.

Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.

Kawakami M, Kawakami K, Takahashi S, Abe M, Puri RK.

Cancer. 2004 Sep 1;101(5):1036-42.

PMID:
15329913
[PubMed - indexed for MEDLINE]
Free Article
19.

Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain.

Kawakami K, Takeshita F, Puri RK.

J Biol Chem. 2001 Jul 6;276(27):25114-20. Epub 2001 May 14.

PMID:
11352909
[PubMed - indexed for MEDLINE]
Free Article
20.

IL-13 cytotoxin has potent antitumor activity and synergizes with paclitaxel in a mouse model of oral squamous cell carcinoma.

Kioi M, Shimamura T, Nakashima H, Hirota M, Tohnai I, Husain SR, Puri RK.

Int J Cancer. 2009 Mar 15;124(6):1440-8. doi: 10.1002/ijc.24067.

PMID:
19065664
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk